为您找到相关结果约500个

你是不是要搜索 期刊条形码： 0161433314 检测项目： PD-L1(Roche，SP263)全自动免疫组化 点击跳转

Interobserver Reliability of Programmed Cell Death Ligand-1 Scoring Using the VENTANA PD-L1 (SP263) Assay

Programmed cell death ligand-1 (PD-L1) expression in extrahepatic biliary tract cancers: a comparativestudy using 22C3, SP263 and E1L3N anti-PD-L1 antibodies

The PD-1/PD-L pathway in rheumatic diseases

PD-1/PD-L Axis in Neuroinflammation: New Insights

PD-L1 Expression Harmonization in Gastric Cancer Using 22C3 PharmDx and SP263 Assays

PD-1/PD-L Pathway Potentially Involved in ITP Immunopathogenesis

Comparison of 22C3 PharmDx and SP263 Assays to Test PD-L1 Expression in NSCLC

PD-L1 expression in muscle invasive urothelial carcinoma: Comparison of SP142 and SP263 assay

External quality assessment demonstrates that PD-L1 22C3 and SP263 assays are systematically different

The Diverse Function of PD-1/PD-L Pathway Beyond Cancer

Correlation between PD-L1 expression (clones 28-8 and SP263) and histopathology in lung adenocarcinoma

Comparison of PD-L1 Assays in Non-small Cell Lung Cancer: 22C3 pharmDx and SP263

Adjuvant PD-(L)1 Checkpoint Inhibitors

PD-L1 (SP263) staining of fine needle aspirate FFPE samples in NSCLC

Epitope mapping of PD-L1 primary antibodies (28-8, SP142, SP263 E1L3N).

为您找到相关结果约500个

共500条页码: 1/34页15条/页